Lung Organoids in Smoking Research: Current Advances and Future Promises

Tobacco smoking has been established to contribute to the pathogenesis of various respiratory diseases including chronic obstructive pulmonary disease (COPD), lung cancer, and asthma. However, major hurdles in mechanistic studies on the role of smoking in human lungs remain in part due to the lack of ex vivo experimental models and ambiguous data from animal models that can best recapitulate the architecture and pathophysiology of the human lung. Recent development of the lung organoid culture system has opened new avenues for respiratory disease research as organoids are proving to be a sophisticated ex vivo model that functionally and structurally mimics the human lungs better than other traditionally used models. This review will discuss how recent advances in lung organoid systems may help us better determine the injurious and immunological effect of smoking on human lungs and will provide some suggestions for future research directions.

Automated summary

Smoking is known to contribute to various respiratory diseases, but studying its mechanisms in human lungs has been challenging. The lung organoid culture system, as a sophisticated ex vivo model, shows promise in investigating the harmful and immunological effects of smoking on human lungs and guiding future research directions.